BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15769087)

  • 1. Affinity enhancement bivalent morpholino for pretargeting: initial evidence by surface plasmon resonance.
    He J; Liu G; Vanderheyden JL; Dou S; Mary R; Hnatowich DJ
    Bioconjug Chem; 2005; 16(2):338-45. PubMed ID: 15769087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Affinity enhancement bivalent morpholinos for pretargeting: surface plasmon resonance studies of molecular dimensions.
    He J; Liu X; Zhang S; Liu G; Hnatowich DJ
    Bioconjug Chem; 2005; 16(5):1098-104. PubMed ID: 16173785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Affinity enhancement pretargeting: synthesis and testing of a 99mTc-labeled bivalent MORF.
    He J; Wang Y; Dou S; Liu X; Zhang S; Liu G; Hnatowich D
    Mol Pharm; 2010 Aug; 7(4):1118-24. PubMed ID: 20507096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of in vitro and in vivo stability in mice of two morpholino duplexes differing in chain length.
    He J; Liu G; Zhang S; Vanderheyden JL; Liu N; Liu C; Zhang Y; Gupta S; Rusckowski M; Hnatowich DJ
    Bioconjug Chem; 2003; 14(5):1018-23. PubMed ID: 13129406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting of bivalent anti-ErbB2 diabody antibody fragments to tumor cells is independent of the intrinsic antibody affinity.
    Nielsen UB; Adams GP; Weiner LM; Marks JD
    Cancer Res; 2000 Nov; 60(22):6434-40. PubMed ID: 11103810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial investigations of 99mTc-labeled morpholinos for radiopharmaceutical applications.
    Mang'era KO; Liu G; Yi W; Zhang Y; Liu N; Gupta S; Rusckowski M; Hnatowich DJ
    Eur J Nucl Med; 2001 Nov; 28(11):1682-9. PubMed ID: 11702111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optical pretargeting of tumor with fluorescent MORF oligomers.
    He J; Rusckowski M; Wang Y; Dou S; Liu X; Zhang S; Liu G; Hnatowich DJ
    Mol Imaging Biol; 2007; 9(1):17-23. PubMed ID: 17171474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simplified preparation via streptavidin of antisense oligomers/carriers nanoparticles showing improved cellular delivery in culture.
    Wang Y; Nakamura K; Liu X; Kitamura N; Kubo A; Hnatowich DJ
    Bioconjug Chem; 2007; 18(4):1338-43. PubMed ID: 17605463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An improved method for covalently conjugating morpholino oligomers to antitumor antibodies.
    He J; Liu G; Dou S; Gupta S; Rusckowski M; Hnatowich D
    Bioconjug Chem; 2007; 18(3):983-8. PubMed ID: 17385902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mono and bivalent binding of a scFv and covalent diabody to murine laminin-1 using radioiodinated proteins and SPR measurements: effects on tissue retention in vivo.
    Huang BC; Davern S; Kennel SJ
    J Immunol Methods; 2006 Jun; 313(1-2):149-60. PubMed ID: 16750217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discrimination of hairpin polyamides with an alpha-substituted-gamma-aminobutyric acid as a 5'-TG-3' reader in DNA minor groove.
    Zhang W; Bando T; Sugiyama H
    J Am Chem Soc; 2006 Jul; 128(27):8766-76. PubMed ID: 16819870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic resolution of bimolecular hybridization versus intramolecular folding in nucleic acids by surface plasmon resonance: application to G-quadruplex/duplex competition in human c-myc promoter.
    Halder K; Chowdhury S
    Nucleic Acids Res; 2005; 33(14):4466-74. PubMed ID: 16085756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing recombinant antibody function in SPR immunosensing. The influence of antibody structural format and chip surface chemistry on assay sensitivity.
    Townsend S; Finlay WJ; Hearty S; O'Kennedy R
    Biosens Bioelectron; 2006 Aug; 22(2):268-74. PubMed ID: 16487701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of concentration and binding affinity of antibody fragments by use of surface plasmon resonance.
    Kikuchi Y; Uno S; Nanami M; Yoshimura Y; Iida S; Fukushima N; Tsuchiya M
    J Biosci Bioeng; 2005 Sep; 100(3):311-7. PubMed ID: 16243282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent bivalent inhibition of human tryptase-beta by a synthetic inhibitor.
    Selwood T; Elrod KC; Schechter NM
    Biol Chem; 2003 Dec; 384(12):1605-11. PubMed ID: 14719803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface plasmon resonance spectroscopy study of interfacial binding of thrombin to antithrombin DNA aptamers.
    Tang Q; Su X; Loh KP
    J Colloid Interface Sci; 2007 Nov; 315(1):99-106. PubMed ID: 17689549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of two- and three-dimensional streptavidin binding platforms for surface plasmon resonance spectroscopy studies of DNA hybridization and protein-DNA binding.
    Yang N; Su X; Tjong V; Knoll W
    Biosens Bioelectron; 2007 May; 22(11):2700-6. PubMed ID: 17223028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding analysis of 1alpha- and 17alpha-dihydrotestosterone derivatives to homodimeric sex hormone-binding globulin.
    Metzger J; Schnitzbauer A; Meyer M; Söder M; Cuilleron CY; Hauptmann H; Huber E; Luppa PB
    Biochemistry; 2003 Nov; 42(46):13735-45. PubMed ID: 14622020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting the biodistribution of radiolabeled cMORF effector in MORF-pretargeted mice.
    Liu G; Dou S; He J; Liu X; Rusckowski M; Hnatowich DJ
    Eur J Nucl Med Mol Imaging; 2007 Feb; 34(2):237-46. PubMed ID: 17021815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Affinity constants for small molecules from SPR competition experiments.
    de Mol NJ
    Methods Mol Biol; 2010; 627():101-11. PubMed ID: 20217616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.